TOM STOPPARD did not write all the best lines in Shakespeare in Love, but the film's assertion that for a successful comedy all you need is "love and a bit with a dog" is unlikely to have been a Bard ...

Bioglan Pharma, the biotech firm fighting for survival in the face of mounting debts, has again failed to get its results approved by its auditors. The company restated its most recent interim results ...

The treatment of two closely timed deals made a big difference to one year's profits. But later the auditor revised its advice. Richard Fletcher unravels the pharmaceutical group's accounts January 31 ...

BIOGLAN, the beleaguered British pharmaceutical which is to sell its generic drugs business in Dublin and cut 15pc of its workforce after the collapse of its stg£527m takeover of skincare products, ...

Terry Sadler, the entrepreneur behind Bioglan Pharma, the dermatology firm which crashed into administration two years ago amid claims of accounting irregularities, is returning to the stock market.

Pharmaceutical company Bioglan Pharma has expanded its links with Novartis, having already acquired a number of steroid products for the German market from Novartis. Bioglan has licensed and has the ...

Bioglan, the skincare group fighting to stay afloat in the face of mounting debts, has been accused of misleading the market over the progress of clinical trials. The company told investors in August ...